Critical analysis of ineffective post implantation implantable cardioverter-defibrillator-testing.
Pre-implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation.
Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation.
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N; ESC Scientific Document Group.
Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246.
Critical analysis of ineffective post implantation implantable cardioverter-defibrillator-testing.
Roos M, Geller JC, Ohlow MA.
World J Cardiol. 2017 Feb 26;9(2):167-173. doi: 10.4330/wjc.v9.i2.167.
Performance of the Linox implantable cardioverter defibrillator leads: A single-center experience.
Marai I, Milman A, Nof E, Gurevitz O, Barlev D, Lipchenca I, Bachar S, Glikson M, Beinart R.
Pacing Clin Electrophysiol. 2019 Dec;42(12):1524-1528. doi: 10.1111/pace.13816. Epub 2019 Oct 30.
Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience.
Wieniawski P, Buczyński M, Grabowski M, Winter J, Werner B.
Int J Environ Res Public Health. 2022 Sep 16;19(18):11661. doi: 10.3390/ijerph191811661.
Pre-implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation.
Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA.
Int J Cardiol. 2013 Jun 5;166(1):215-20. doi: 10.1016/j.ijcard.2011.10.092. Epub 2011 Nov 8.
Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator.
Morris PL, Badger J, Chmielewski C, Berger E, Goldberg RJ.
Psychosomatics. 1991 Winter;32(1):58-64. doi: 10.1016/S0033-3182(91)72112-9.
Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: A cost-effectiveness analysis.
Romero J, Rodriguez-Taveras J, Diaz JC, Lorente-Ros M, Braunstein ED, Alviz I, Parides M, Haroun MW, Papa L, Dave K, Rodriguez D, Krishnan S, Toquica C, Velasco A, Gabr M, Natale A, Di Biase L.
Heart Rhythm. 2023 Apr;20(4):522-529. doi: 10.1016/j.hrthm.2022.12.018. Epub 2022 Dec 21.
Failure-free survival of the Riata implantable cardioverter-defibrillator lead after a very long-term follow-up.
San Antonio R, Guasch E, Chipa-Ccasani F, Apolo J, Pujol-López M, Fernández H, Trotta O, Niebla M, Borràs R, Trucco E, Arbelo E, Roca-Luque I, Brugada J, Mont L, Tolosana JM.
Indian Pacing Electrophysiol J. 2019 Jul-Aug;19(4):140-144. doi: 10.1016/j.ipej.2019.02.005. Epub 2019 Feb 19.
Sex differences in the course of implantable cardioverter defibrillator concerns (Results from the Danish national DEFIB-WOMEN study).
Andersen CM, Johansen JB, Wehberg S, Nielsen JC, Riahi S, Haarbo J, Philbert BT, Pedersen SS; DEFIB-WOMEN Investigators.
J Psychosom Res. 2023 Jan;164:111072. doi: 10.1016/j.jpsychores.2022.111072. Epub 2022 Nov 5.
Real-world evidence for the use of subcutaneous implantable cardioverter-defibrillators in China: A single-center experience.
Zhang L, Li X, Liang Y, Wang J, Li M, Pan L, Chen X, Qin S, Bai J, Wang W, Su Y, Ge J.
Herz. 2023 Dec;48(6):462-469. doi: 10.1007/s00059-023-05192-4. Epub 2023 Aug 4.
